methylene dimethanesulfonate has been researched along with Soft Tissue Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blackledge, G; Havsteen, H; Kerbrat, P; Mouridsen, HT; Somers, R; Steward, WP; Sylvester, R; Thomas, D; Van Oosterom, AT; Verweij, J | 1 |
1 other study(ies) available for methylene dimethanesulfonate and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Phase II trial of methylene dimethane sulphonate (MDMS) in advanced soft tissue sarcomas of the adult. A study of the EORTC Soft Tissue and Bone Sarcoma Group.
Topics: Adult; Aged; Alkylating Agents; Drug Evaluation; Female; Humans; Male; Methyl Methanesulfonate; Middle Aged; Sarcoma; Soft Tissue Neoplasms | 1989 |